Association of snuff use with chronic bronchitis among South African women: Implications for tobacco harm reduction

Tobacco Control

Volumn 17, Issue 2, 2008, Pages 99-104

  Ayo Yusuf, O A ^a   Reddy, P S ^b   Van Den Borne, B W ^c  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CHRONIC BRONCHITIS; COUGHING; CROSS-SECTIONAL STUDY; ETHNOLOGY; FEMALE; HARM REDUCTION; HEALTH; HUMAN; MIDDLE AGED; NEGRO; PREVALENCE; RISK FACTOR; SMOKELESS TOBACCO; SOCIOECONOMICS; SOUTH AFRICA;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BRONCHITIS, CHRONIC; COUGH; CROSS-SECTIONAL STUDIES; FEMALE; HARM REDUCTION; HUMANS; MIDDLE AGED; PREVALENCE; RISK FACTORS; RURAL HEALTH; SOCIOECONOMIC FACTORS; SOUTH AFRICA; TOBACCO, SMOKELESS; URBAN HEALTH;

EID: 42149174334     PISSN: 09644563     EISSN: None     Source Type: Journal    
DOI: 10.1136/tc.2007.022608     Document Type: Article

References (43)

1. Steyn K, Bradshaw D, Norman R, et al. Tobacco use in South Africans during 1998: the first demographic and health survey. J Cardiovasc Risk 2002;9:161-70.
2. Swart D. Reddy P, Panday S, et al. The 2002 Global Youth Tobacco Survey (GYTS): the 2nd GYTS in South Africa - a comparison between GYTS (SA) 1999 and GYTS (SA) 2002. Cape Town. South Africa: South African Medical Research Council, 2004.
3. Ayo-Yusuf OA, Swart TJP, Pickworth WB. Nicotine delivery capabilities of smokeless tobacco products and implications for control of tobacco dependence in South Africa. Tob Control 2004;13:186-9.
4. Ayo-Yusuf OA, Peltzer K, Mufamadi J. Traditional healers' perception of smokeless tobacco use and health in the Limpopo Province of South Africa. Subst Use Misuse 2006;41:211-22.
5. Stratton K, Shetty P, Wallas P, et al. Clearing the smoke: assessing the science base for tobacco harm reduction. Washington DC, USA: National Academy of Sciences, National Academy Press, 2001.
6. Critchley JA, Unal B. Health effects associated with smokeless tobacco: a systematic review. Thorax 2003;58:435-43.
7. Peltzer K. Smokeless tobacco and cigarette use among black secondary school students in South Africa. Subst Use Misuse 2003;38:1003-16.
8. SmokeLess New Zealand. Nasal snuff - a traditional, less harmful way to use tobacco. http://www.smokeless.org.nz/nasalsnuffMay06.pdf (accessed 5 Jun 2007).
9. BBC News Magazine. Sniffing out the smoking ban. http://news.bbc.co.Uk/1/hi/magazine/4942446.stm (accessed 5 Jun 2007).
10. England U, Levin RJ, Mills JL, et al. Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol 2003;189:939-43.
11. Winn DM, Blot WJ, Shy C, et al. Snuff dipping and oral cancer among women in the southern United States. N Engl J Med 1981;304:745-9.
12. Idris AM, Ahmed HM, Malik MOA. Toombak dipping and cancer of the oral cavity in the Sudan: a case-control study. Int J Cancer 1995;63:477-80.
13. Rodu B, Cole P. Smokeless tobacco use and cancer of the upper respiratory tract. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:511-5.
14. Alguacil J, Silverman DT. Smokeless and other noncigarette tobacco use and pancreatic cancer: a case control study based on direct interviews. Cancer Epidemiol Biomarkers Prev 2004;13:55-8.
15. Gupta PC, Mehta HC. Cohort study of all-cause mortality among tobacco users in Mumbai. India. Bull World Health Organ 2000;78:877-83.
16. Henley SJ, Thun MJ, Connell C, et al. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control 2005;16:347-58.
17. Accortt NA, Waterbor JW, Beall C, et al. Chronic disease mortality in a cohort of smokeless tobacco users. Am J Epidemiol 2002;156:730-7.
18. Accortt NA, Waterbor JW, Beall C, et al. Cancer incidence among a cohort of smokeless tobacco users (United States). Cancer Causes Control 2005;16:1107-15.
19. Sasco AJ, Merill RM, Dari I, et al. A case-control study of lung cancer in Casablanca, Morocco. Cancer Causes Control 2002;13:609-16.
20. Sapundzhiev N, Werner JA. Nasal snuff: historical review and health related aspects. J Laryngol Otol 2003;117:686-91.
21. Dygert HP. Snuff: a source of pathogenic bacteria in chronic bronchitis. N Eng J Med 1957;257:311-13.
22. Ayo-Yusuf OA, Van Wyk C, Van Wyk CW, et al. Smokeless tobacco products on the South African market do not inhibit oral bacterial flora: a pilot study. S African J Epidemiol Infect 2005;20:136-9.
23. Hummer B, Purnama I, Hahn HL. Stimulation of submucosal glands by nicotine applied locally to the airway mucosa. Klin Wochenschr 1988;66:161-9.
24. Ehrlich RI, White N, Norman R, et al. Predictors of chronic bronchitis in South Africa. Int J Tuberc Lung Dis 2004;8:369-76.
25. Medical Research Council. Respiratory symptoms questionnaire. London, UK: MRC, 1976.
26. Cerviri I, Accordini S, Verlato G, et al. Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults. Eur Respir J 2001;18:85-92.
27. Ayo-Yusuf OA, Swart TJP, Ayo-Yusuf IJ. Prevalence and pattern of snuff dipping in a rural South African population. SADJ 2000;55:610-4.
28. Bjartveit K, Tverdal A. Health consequences of smoking 1-4 cigarettes per day. Tob Control 2005;14:315-20.
29. Simmons MS, Connett JE, Nides MA, et al. Smoking reduction and the rate of decline in FEV1 : results from the Lung Health Study. Eur Respir J 2005;25:1011-17.
30. Sreedharan S, Kamath MP, Khadilkar U, et al. Effect of snuff on nasal mucosa. Am J Otolaryngol 2005:26:151-6.
31. Montnémery P, Svensson C, Ädelroth E, et al. Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. Eur Respir J 2001;17:596-603.
32. Randhawa K, Mendes E. Wanner A. Acute effect of cigarette smoke and nicotine on airway blood flow and airflow in healthy smokers. Lung 2006;184:363-8.
33. Hansson L, Choudry NB, Karlsson JA, et al. Inhaled nicotine in humans: effect on the respiratory and cardiovascular systems. J Appl Physiol 1994;76:2420-7.
34. Lee LY, Burki NK, Gerhardstein DC, et al. Airway irritation and cough evoked by inhaled cigarette smoke: role of neuronal nicotinic acetylcholine receptors. Pulm Pharmacol Ther 2007;20:355-64.
35. Aoshiba K, Nagai A, Yasui S, et al. Nicotine prolongs neutrophil survival by suppressing apoptosis. J Lab Clin Med 1996;127:186-94.
36. Hoidal JR. Pathogenesis of chronic bronchitis. Semin Respir Infect 1994;9:8-12.
37. Bounder GM, Ahlborg BO, Lindell JH. Use of smokeless tobacco: blood pressure elevation and other health harzards found in a large-scale population survey. J Int Med 1992;232:327-34.
38. Lander F, Gravesen S. Respiratory disorders among tobacco workers. Br J Ind Med 1988;45:500-2.
39. Mustajbegovic J, Zuskin E, Schachter EN, et al. Occupational and environmental lung disease. Respiratory findings in tobacco workers. Chest 2003;123:1740-8.
40. Rodu B, Godshall WT. Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Reduct J 2006;3:37.
41. Kozlowski LT, Strasser AA, Giovino GA, et al. Applying the risk/use equilibrium: use medical nicotine now for harm reduction. Tob Control 2001;10:201-3.
42. Ayo-Yusuf OA. Re-emergence of traditional tobacco products' usage in South Africa: an unintended consequence of existing tobacco control policy. African J Drug Alcohol Stud 2005:4:32-43.
43. Van Wyk CW. The oral lesion caused by snuff: a clinico-pathological study. Med Proc 1965;11:531-7.